Vivani Medical
VANI
45 hedge funds and large institutions have $19.2M invested in Vivani Medical in 2021 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 7 closing their positions.
214% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 7
50% more funds holding
Funds holding: 30 → 45 (+15)
29% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 7
1.39% less ownership
Funds ownership: 4.81% → 3.41% (-1.4%)
30% less capital invested
Capital invested by funds: $27.3M → $19.2M (-$8.07M)
77% less call options, than puts
Call options by funds: $735K | Put options by funds: $3.18M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.53M |
| 2 |
ACM
Altium Capital Management
New York
|
+$2.41M |
| 3 |
NAM
NewGen Asset Management
Toronto,
Ontario, Canada
|
+$1.29M |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$896K |
| 5 |
KC
Kepos Capital
New York
|
+$644K |
Top Sellers
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$4.81M |
| 2 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$3.99M |
| 3 |
Jane Street
New York
|
-$256K |
| 4 |
Goldman Sachs
New York
|
-$109K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$103K |
VANI Hedge Fund Activity: Q2 2021 in Review
45 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical (VANI) for Q2 2021, worth a combined $19.2M — down 30% from $27.3M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new VANI positions and 7 closed out — a net gain of 15 holders — while 9 added to existing stakes and 7 trimmed.
The largest buyer was Vanguard Group, adding an estimated $3.53M. The largest seller was Sabby Management, cutting an estimated $4.81M.
- 45 institutional investors held Vivani Medical (VANI) as of Q2 2021, up from 30 in Q1 2021.
- Funds reported $19.2M of Vivani Medical stock for Q2 2021, down 30% quarter-over-quarter.
- 22 funds opened new Vivani Medical positions in Q2 2021 and 7 closed out, a net change of +15 holders.
- The largest Vivani Medical buyer in Q2 2021 was Vanguard Group, an estimated $3.53M added.
- The largest Vivani Medical seller in Q2 2021 was Sabby Management, an estimated $4.81M sold.
Based on aggregated 13F filings for Q2 2021.